Joseph E. Gilliam

Joseph E. Gilliam

DirectoratGLAUKOS· In proxies 2021–2025

Pay in FY2025+87% from the year before

Joseph E. Gilliam was paid $7.8M in FY2025 (Dec), up 87%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each GLAUKOS proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Caris Life SciencesPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. GLAUKOSPublic company · 5 yr
    • President and Chief Operating Officer2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Caris Life SciencesDirector · 4 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?